secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2021-10-06T23:59:59+00:00
Accession:  0001564590-21-050320
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo CFO Jonathan Lieber resigns; Thomas P. Hess appointed as President and CFO
--------------------------------------------------------------------------------

- Jonathan Lieber resigned effective Oct 6, 2021, to pursue a full-time opportunity; no disagreement with the Company.
- Thomas P. Hess, age 57, appointed President, CFO and Principal Financial Officer, effective Oct 6, 2021, through Danforth Advisors at $400/hour.
- At Oct 5, 2021 annual meeting, 45.91% of shares constituted quorum; Alison Tjosvold Milhous elected Class I director.
- Stockholders ratified Mayer Hoffman McCann P.C. as auditor for FY2022 and approved advisory say-on-pay and amendment to 2012 Equity Incentive Plan.
- Plan amended to increase share reserve to 2,327,699 shares and impose annual per-person limits of 400,000 shares and $2,000,000 cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/0001564590-21-050320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/onvo-8k_20211005.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-050320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer